NeoGenomics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NeoGenomics and other ETFs, options, and stocks.

About NEO

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. 

CEO
Christopher Michael Smith
CEOChristopher Michael Smith
Employees
2,000
Employees2,000
Headquarters
Fort Myers, Florida
HeadquartersFort Myers, Florida
Founded
1998
Founded1998
Employees
2,000
Employees2,000

NEO Key Statistics

Market cap
1.14B
Market cap1.14B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.06M
Average volume1.06M
High today
$9.34
High today$9.34
Low today
$8.88
Low today$8.88
Open price
$9.14
Open price$9.14
Volume
673.82K
Volume673.82K
52 Week high
$47.13
52 Week high$47.13
52 Week low
$6.85
52 Week low$6.85

Analyst ratings

54%

of 13 ratings
Buy
53.8%
Hold
46.2%
Sell
0%

NEO Earnings

-$0.23
-$0.15
-$0.07
$0.01
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 3, Pre-Market
ActualExpected Nov 3, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.